Efficacy and Safety of Zilebesiran for the Management of Hypertension: An Updated Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Cureus · 2025 · PMC12530167 · PMID 41111811

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantp-value <0.00001actually significant

The overall pooled analysis demonstrated a highly significant effect, indicating strong evidence for a reduction in 24-hour ambulatory SBP (Z=15.33; p-value <0.00001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.